Neogen (NEOG) Capital Expenditures Growth (3y) (2013 - 2026)
Neogen (NEOG) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -0.66% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 9.94% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 10.89% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 11.78% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 12.81% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 12.62% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 19.51% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 9.52% |
| 10 | Neogen | 2.61 Bn | 2.42 Bn | 107.80 Mn | -46.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -46.07% |
| Feb 28, 2026 | -8.44% |
| Nov 30, 2025 | -1.22% |
| Aug 31, 2025 | 22.69% |
| May 31, 2025 | 8.68% |
| Feb 28, 2025 | 70.36% |
| Nov 30, 2024 | 63.30% |
| Aug 31, 2024 | 209.61% |
| May 31, 2024 | 49.09% |
| Feb 29, 2024 | 57.00% |
| Nov 30, 2023 | 52.80% |
| Aug 31, 2023 | 93.19% |
| May 31, 2023 | 48.87% |
| Feb 28, 2023 | 62.73% |
| Nov 30, 2022 | 24.08% |
| Aug 31, 2022 | 26.18% |
| May 31, 2022 | 65.14% |
| Feb 28, 2022 | 8.88% |
| Nov 30, 2021 | -6.38% |
| Aug 31, 2021 | -12.27% |